Mucin model for group B type III streptococcal infection in mice.
AUTOR(ES)
Fleming, D O
RESUMO
An experimental murine infection was established by the intraperitoneal injection of a log-phase culture of a laboratory reference strain of Streptococcus agalactiae, Lancefield group B, type III (strain SS620), suspended in sterile hog gastric mucin. The enhancement of streptococcal virulence was measured by a significantly increased mortality in outbred ICR Swiss mice. An inbred C57BL6 strain of mice was resistant to the mucin-bacterial combination. Mucin, treated with Desferal to chelate the iron, did not lose the capacity to enhance the virulence of group B, type III streptococci in ICR Swiss mice. Iron-dextran was not a suitable substitute for mucin and failed to enhance the virulence of group B, type III streptococci. The results of these studies indicate that iron is not the resistance-lowering factor in this group B, type III streptococci-mucin model.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=550786Documentos Relacionados
- Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.
- Antimicrobial Therapy of Experimental Group B Streptococcal Infection in Mice
- Adult mice as a model for early onset group B streptococcal disease.
- Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection.
- Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection
